Lisa M Cordes

13PUBLICATIONS
52CO-AUTHORS
Molecular targetsOncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Dental therapeutics, pharmacology and toxicologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 24, 2026
Durable responses to triplet immunotherapy targeting TGF-β, PD-L1, and tumor antigen, with an IL-15 receptor superagonist in mismatch repair proficient castration-resistant prostate cancer.

|Mar 25, 2026
Phase II study of olaparib and durvalumab in patients with metastatic castration-resistant prostate cancer.

Chennan Li, Ravi A Madan, Min-Jung Lee

|Mar 29, 2025
Tri-Ad5 vaccine plus bintrafusp alfa for newly diagnosed, advanced-stage head and neck cancer not associated with human papillomavirus infection.

Jason M Redman, Renee N Donahue, Seth J Steinberg

|Jul 02, 2024
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors.

Andrea B Apolo, Daniel M Girardi, Scot A Niglio

|Jun 13, 2023
Avelumab in Patients With Metastatic Colorectal Cancer.

Jason M Redman, Geraldine O'Sullivan Coyne, Clay T Reed

|May 10, 2023
Relugolix in Clinical Practice: The Best Route for All?

Lisa M Cordes, Fatima Karzai, William D Figg

Pageof 3

Frequent Collaborators

7 joint publications

Jeffrey Schlom

7 joint publications

James L Gulley

4 joint publications

Jason Redman

4 joint publications

Ravi A Madan